FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to chemical-pharmaceutical industry, more specifically to (1-hydroxy-4,5-dimethyl-1H-imidazol-2-yl)(phenyl)methanonoxime of formula (1)
EFFECT: what is prepared is a new compound possessing antiarrhythmic activity and low toxicity.
2 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
5'-BROMOLAPPACONITINE HYDROBROMIDE POSSESSING ANTI-ARRHYTHMIC ACTIVITY | 2005 |
|
RU2295524C1 |
N-(BETA-HYDROXYETHYL)-CYTISINE HYDROCHLORIDE ELICITING ANTI-ARRHYTHMIC ACTIVITY | 2002 |
|
RU2228179C2 |
ANTIARRHYTHMIC DRUG BASED ON HYBRID MOLECULES OF AMLODIPINE WITH (7-METHOXICUMARIN-4-YL)ACETIC ACID | 2018 |
|
RU2678969C1 |
NON-6-ENE HYDROCHLORIDE ELICITING ANTI-ARRHYTHMIC ACTIVITY | 2002 |
|
RU2228334C2 |
METHOD FOR SELECTION OF MOST EFFECTIVE ANTIARRHYTHMIC DRUG FOR PATIENTS WITH EXTRASISTOLY | 2017 |
|
RU2641164C1 |
METHOD FOR SELECTING AN EFFECTIVE ANTIARRHYTHMIC AGENT FOR PATIENTS WITH PREMATURE HEART BEATS | 2019 |
|
RU2707261C1 |
5-AMINO-EXO-3-AZATRICYCLO[5.2.1.0]-DECAN-4-ONE HAVING ANTI-ARRHYTHMIC, ANTI-INFLAMMATION, ANALGESIC, AND NOOTHROPIC ACTIVITY | 2005 |
|
RU2281938C1 |
ANTIARRHYTHMIC DRUG | 2017 |
|
RU2664668C1 |
2-(2-(DIALKYLAMINO POLYETHOXY))ETHYL CARBOXYLATES AND HYDROCHLORIDES THEREOF WITH ANTIARRHYTHMIC ACTIVITY AND PHARMACEUTICAL COMPOSITIONS BASED THEREON | 2020 |
|
RU2775616C2 |
THERAPEUTIC AGENT FOR TREATMENT OF DIFFERENT FORMS OF HEART RHYTHM DISTURBANCES | 2000 |
|
RU2180583C1 |
Authors
Dates
2013-04-10—Published
2012-02-16—Filed